Amvuttra TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: vutrisiran
Pack: Amvuttra 25 mg/0.5 mL injection, 0.5 mL syringe
Brand name
(ARTG)
: AMVUTTRA, vutrisiran (as sodium) 25 mg / 0.5 mL solution for injection pre-filled syringeWhat this medicine is used for
(ARTG)
Amvuttra is indicated for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Subcutaneous
- Clear, colorless to yellow sterile solution practically free from visible particles
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Do not Freeze
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 x 0.5 mL pre-filled syringe pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient vutrisiran
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
